Index of artpub/2024/310572/

Herencia Ropero, Andrea
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models
2024
https://ddd.uab.cat/record/310572